These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11085806)

  • 1. Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis.
    Nagashima M; Wauke K; Hirano D; Ishigami S; Aono H; Takai M; Sasano M; Yoshino S
    Rheumatology (Oxford); 2000 Nov; 39(11):1255-62. PubMed ID: 11085806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells.
    Nagashima M; Yoshino S; Aono H; Takai M; Sasano M
    Clin Exp Immunol; 1999 May; 116(2):360-5. PubMed ID: 10337031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of disease modifying antirheumatic drugs (DMARDs) and DEX on IL-1 beta and IL-6 production by IL-1 beta stimulated synovial culture cells].
    Koda M; Yoshino S; Nakamura H; Asano G
    Nihon Ika Daigaku Zasshi; 1996 Oct; 63(5):419-23. PubMed ID: 8937133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential influences of bucillamine and methotrexate on the generation of fibroblast-like cells from bone marrow CD34+ cells of rheumatoid arthritis patients.
    Hirohata S; Yanagida T; Tomita T; Yoshikawa H
    Int Immunopharmacol; 2009 Jan; 9(1):86-90. PubMed ID: 19000788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
    Nagashima M; Asano G; Yoshino S
    J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs.
    Loetscher P; Dewald B; Baggiolini M; Seitz M
    Cytokine; 1994 Mar; 6(2):162-70. PubMed ID: 8031999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes.
    Kusabe T; Waguri-Nagaya Y; Tanikawa T; Aoyama M; Fukuoka M; Kobayashi M; Otsuka T; Asai K
    Rheumatol Int; 2005 Oct; 25(8):625-30. PubMed ID: 15990992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential influences of gold sodium thiomalate and bucillamine on the generation of CD14+ monocyte-lineage cells from bone marrow of rheumatoid arthritis patients.
    Hirohata S; Yanagida T; Hashimoto H; Tomita T; Ochi T; Nakamura H; Yoshino S
    Clin Immunol Immunopathol; 1997 Sep; 84(3):290-5. PubMed ID: 9281388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
    Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
    Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine.
    Aono H; Hasunuma T; Fujisawa K; Nakajima T; Yamamoto K; Mita S; Nishioka K
    J Rheumatol; 1996 Jan; 23(1):65-70. PubMed ID: 8838510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. epidemiology of DMARDs treatment in Japan.
    Nagashima M; Shu G; Yamamoto K; Yamahatsu S; Yoshino S
    Clin Exp Rheumatol; 2005; 23(1):27-35. PubMed ID: 15789884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
    Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM
    Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of bizhongxiao decoction on the expression of VEGF in the synovial membrane of C II-induced rheumatoid arthritis in rats].
    Liang QH; He JH; Li XL
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):491-4. PubMed ID: 12658918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts.
    Cho ML; Cho CS; Min SY; Kim SH; Lee SS; Kim WU; Min DJ; Min JK; Youn J; Hwang SY; Park SH; Kim HY
    Arthritis Rheum; 2002 May; 46(5):1202-9. PubMed ID: 12115224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts.
    Kasama T; Shiozawa F; Kobayashi K; Yajima N; Hanyuda M; Takeuchi HT; Mori Y; Negishi M; Ide H; Adachi M
    Arthritis Rheum; 2001 Nov; 44(11):2512-24. PubMed ID: 11710707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bucillamine mechanism inhibiting IL-1beta-induced VEGF production from fibroblast-like synoviocytes.
    Tsuji F; Seki I; Aono H; Odani N; Mizutani K; Okamoto M; Sasano M
    Int Immunopharmacol; 2007 Dec; 7(12):1569-76. PubMed ID: 17920534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis.
    Suematsu A; Tajiri Y; Nakashima T; Taka J; Ochi S; Oda H; Nakamura K; Tanaka S; Takayanagi H
    Mod Rheumatol; 2007; 17(1):17-23. PubMed ID: 17278017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells.
    Cheng T; Cao W; Wen R; Steinberg RH; LaVail MM
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):581-91. PubMed ID: 9501870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.